Small Doses: October 28 to November 1
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Best Practices for Educating Patients on Holistic Weight Management Approaches | NCPA 2024
A conversation with Melody Hartzler, PharmD, at the 2024 National Community Pharmacists Association Annual Convention and Expo.
Infliximab Monotherapy Effective as Combo Therapy for Treating Inflammatory Bowel Disease
Researchers from Celltrion USA presented their post hoc analysis from the LIBERTY studies at the American College of Gastroenterology 2024 Annual Scientific Meeting.
Weekly Semaglutide Injection Reduces Knee Osteoarthritis Pain
In a recent clinical trial, weekly semaglutide demonstrated promise as a nonsurgical, nonopioid intervention for reducing knee osteoarthritis pain.
FDA Roundup: Agency Highlights from October 2024
Check out these important FDA updates from the month of October 2024.
How to Turn Patient Visits into Clinical Encounters in the Pharmacy | NCPA 2024
Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.
Ketamine Improved Chronic Pain for Patients with Cancer Following Surgery
Researchers conducted a systematic review of randomized trials to determine the efficacy of ketamine for patients with cancer.
Weathering the Storm: Medication Preparedness in Hurricane Season
Hurricane season brings extreme weather and health care disruptions, emphasizing the importance of medication preparedness for patients and pharmacists.
Independent Pharmacies Should Expand Their Vaccination Programs | NCPA 2024
A conversation with David Ha, PharmD, BCIDP, at the National Community Pharmacists Association 2024 Annual Convention and Expo.
GoodRx, Opill Partner on OTC Delivery Program to Address Gaps in Access
GoodRx’s new e-commerce service further expands access to Opill by allowing consumers to order the birth control directly to their homes without a prescription.
Patient Engagement and the Future of Community Pharmacy as a Health Care Destination
Ian Stone, Senior Vice President at Mesmerize, discussed the essential aspects of a community pharmacy and how his company can help independent owners excel in the future.
The Essential Tech Stack for Pharmacy Owners
Lisa Faast, PharmD, Founder and CEO of Diversify Rx, discussed how technology is used to innovate within the pharmacy.
Women with Delayed Menopause May Face Increased Risk of Asthma
Women experiencing later menopause may face a heightened risk of asthma, underscoring the possible role of estrogen in the development of the condition.
Meet the Specialty Pharmacist Championing HIV Care
Cassandra Esperant, PharmD, AAHIVP, leverages her skills as a clinical pharmacist to champion the health of patients with HIV, both in her clinical practice and through education initiatives.
Risk of Parkinson Disease Increases With Gastrointestinal Mucosal Damage
Researchers addressed the gut-first hypothesis of Parkinson disease by identifying how mucosal damage impacts risk of development.
Navigating the Future: Key Technology Updates Every Community Pharmacist Should Know for 2024
Timothy Aungst, PharmD, Founder of The Digital Apothecary, discussed advancements in digital health and what to be aware of regarding the future of technology.
Best Practices for Proactively Preventing PBM Audit Issues | NCPA 2024
Trent Thiede, PharmD, MBA, president of PAAS National, discusses best practices that pharmacy teams can implement to proactively prevent audit issues before they arise.
Leveraging US Prescription Market Insights to Drive Pharmacy Innovation
Scott Biggs, Director of Supplier Services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.
Guselkumab’s Promising Results as First Subcutaneous IL-23 Inhibitor to Treat Crohn’s
Johnson & Johnson announced results from its phase 3 GRAVITI trial exploring guselkumab’s results in subcutaneous (SC) induction and maintenance therapy for treating Crohn’s disease.
How Participating in Pharma-Sponsored Programs Can Benefit Your Pharmacy
A.J. Lipka, Business Development Lead of Network Growth at Outcomes, discussed the impact of pharmacy-sponsored programming.
FDA Approves Abuse-Deterrent 10 mg Oxycodone Hydrochloride for Severe Pain
The addition of a 10 mg oxycodone hydrochloride tablet improves dosing flexibility and precision.
Importance of NCPA’s Annual Conference to the Independent Pharmacy Community | NCPA 2024
At the NCPA 2024 Annual Convention and Expo, Drug Topics asked different pharmacists what they think the importance of the conference is to the independent pharmacy community.
Tools Pharmacists Can Use to Identify, Address Metabolic Roadblocks to Weight Loss | NCPA 2024
Melody Hartzler, PharmD, discusses common metabolic roadblocks to weight loss and what tools pharmacy teams can use to identify and address them.
Potential Applications, Risks of AI in the Pharmacy | NCPA 2024
A conversation with Sean Jeffery, PharmD, BCGP, FASCP, AGSF, director of pharmacy at Hartford HealthCare Integrated Care Partners and professor of pharmacy practice at the University of Connecticut.
Advancements Needed in Treating, Identifying Drug-Induced Liver Injury
Researchers analyzed the lack of prevention and treatment options for managing drug-induced liver injury.
Hormonal Contraceptive Prescribing Benefits Patients, Pharmacies | NCPA 2024
With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.
ICYMI: Drug Topics September/October 2024 Issue
Don’t miss out on the latest pharmacy insights in the Drug Topics September/October issue.
Mid-Meeting Recap | NCPA 2024
The NCPA 2024 Annual Convention and Expo runs through October 29, 2024, in Columbus, Ohio.
Top Tips for Pharmacy Vaccination Clinics | NCPA 2024
Before marketing your pharmacy’s immunizations services, check out these takeaways from NCPA.
Specialty Pharmacist Paving the Way for Biosimilar Adoption
A conversation with Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic.